Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorders
ADR ID BADD_A01285
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10013317
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01012Gemfibrozil--
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01022Gliclazide--
BADD_D01038Goserelin--
BADD_D01059Heparan sulfate--
BADD_D01060Heparin--
BADD_D01061Heparin sodium--
BADD_D01073Histrelin--
BADD_D01083Hydrochlorothiazide0.000025%
BADD_D01091Hydrocortisone sodium succinate--
BADD_D01102Hydroxybutanoic acid--
BADD_D01103Hydroxychloroquine--
BADD_D01117Ibandronic acid--
BADD_D01120Ibuprofen--
BADD_D01130Idelalisib--
BADD_D01136Imatinib0.000392%
BADD_D01142Imiquimod--
BADD_D01150Indinavir--
BADD_D01151Indinavir sulfate--
BADD_D01159Insulin (human)--
BADD_D01160Insulin aspart--
BADD_D01161Insulin degludec--
BADD_D01162Insulin detemir--
BADD_D01163Insulin glargine--
BADD_D01164Insulin glulisine--
BADD_D01165Insulin lispro--
BADD_D01166Interferon alfa-2a--
BADD_D01167Interferon alfa-2b--
BADD_D01171Interferon gamma-1b--
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target